Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studies-Reference-Cited by-同舟云学术

Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studies

Published:2002-01-07 Issue:1 Volume:16 Page:87-99
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Tytgat G. N. J.,Van Nueten L.,Van De Velde I.,Joslyn A.,Hanauer S. B.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2002.01121.x/fullpdf

Reference18 articles.

1. Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway;Donowitz;Gastroenterology,1985

2. Eicosanoids and the gastrointestinal tract;Eberhart;Gastroenterology,1995

3. Role of eicosanoids in human and experimental colitis;Schumert;Dig Dis Sci,1988

4. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine;Ligumsky;Gastroenterology,1981

5. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis;Casellas;Eur J Gastroenterol Hepatol,1995

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory bowel disease and cardiovascular diseases: a concise review;European Heart Journal Open;2021-10-14

2. Platelets in Inflammatory Bowel Disease;Platelets in Thrombotic and Non-Thrombotic Disorders;2017

3. Epidemiology, risk factors and management of cardiovascular diseases in IBD;Nature Reviews Gastroenterology & Hepatology;2014-12-02

4. Novel Nonbiologic Therapies for Ulcerative Colitis;Medical Therapy of Ulcerative Colitis;2014

5. The Effect of Antiplatelet Therapy in Patients With Inflammatory Bowel Disease;Journal of Clinical Gastroenterology;2012-07